| Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications V Abbing-Karahagopian, C Huerta, PC Souverein, F De Abajo, ... European journal of clinical pharmacology 70, 849-857, 2014 | 205 | 2014 |
| Indications for antidepressant drug prescribing in general practice in the Netherlands H Gardarsdottir, ER Heerdink, L van Dijk, ACG Egberts Journal of affective disorders 98 (1-2), 109-115, 2007 | 191 | 2007 |
| Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross‐national descriptive study from the PROTECT‐EU … C Huerta, V Abbing‐Karahagopian, G Requena, B Oliva, Y Alvarez, ... Pharmacoepidemiology and drug safety 25, 56-65, 2016 | 155 | 2016 |
| Initiation of antidepressant therapy: do patients follow the GP's prescription? ECG van Geffen, H Gardarsdottir, R van Hulten, L van Dijk, ACG Egberts, ... British Journal of General Practice 59 (559), 81-87, 2009 | 134 | 2009 |
| The high impact of penicillin allergy registration in hospitalized patients SM van Dijk, H Gardarsdottir, MWM Wassenberg, JJ Oosterheert, ... The Journal of Allergy and Clinical Immunology: In Practice 4 (5), 926-931, 2016 | 131 | 2016 |
| Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length H Gardarsdottir, PC Souverein, TCG Egberts, ER Heerdink Journal of clinical epidemiology 63 (4), 422-427, 2010 | 129 | 2010 |
| Pharmacists’ activities to reduce medication waste: an international survey CL Bekker, H Gardarsdottir, ACG Egberts, ML Bouvy, BJF Van den Bemt Pharmacy 6 (3), 94, 2018 | 79 | 2018 |
| The majority of patients do not store their biologic disease-modifying antirheumatic drugs within the recommended temperature range ND Vlieland, H Gardarsdottir, ML Bouvy, TCG Egberts, BJF van den Bemt Rheumatology 55 (4), 704-709, 2016 | 69 | 2016 |
| Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: a population‐based nested case–control study Y Zhang, PC Souverein, H Gardarsdottir, HA van den Ham, ... British journal of clinical pharmacology 86 (6), 1150-1164, 2020 | 67 | 2020 |
| Opportunities and challenges for decentralized clinical trials: European regulators’ perspective AJ de Jong, TI van Rijssel, MGP Zuidgeest, GJMW van Thiel, S Askin, ... Clinical Pharmacology & Therapeutics 112 (2), 344-352, 2022 | 65 | 2022 |
| Patient and medication factors associated with preventable medication waste and possibilities for redispensing CL Bekker, BJF Van Den Bemt, ACG Egberts, ML Bouvy, H Gardarsdottir International journal of clinical pharmacy 40, 704-711, 2018 | 63 | 2018 |
| Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): A cross‐national … L Ibáñez, M Sabaté, X Vidal, E Ballarin, M Rottenkolber, S Schmiedl, ... British Journal of Clinical Pharmacology 85 (11), 2524-2539, 2019 | 61 | 2019 |
| Incidence rates and trends of hip/femur fractures in five European countries: comparison using e-healthcare records databases G Requena, V Abbing-Karahagopian, C Huerta, ML De Bruin, Y Alvarez, ... Calcified tissue international 94, 580-589, 2014 | 55 | 2014 |
| Duration of antidepressant drug treatment and its influence on risk of relapse/recurrence: immortal and neglected time bias H Gardarsdottir, TC Egberts, JJ Stolker, ER Heerdink American journal of epidemiology 170 (3), 280-285, 2009 | 52 | 2009 |
| Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases … G Requena, C Huerta, H Gardarsdottir, J Logie, R González‐González, ... pharmacoepidemiology and drug safety 25, 66-78, 2016 | 51 | 2016 |
| Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease K Orsel, H Taipale, AM Tolppanen, M Koponen, A Tanskanen, J Tiihonen, ... European Neuropsychopharmacology 28 (11), 1260-1269, 2018 | 49 | 2018 |
| Redispensing of medicines unused by patients: a qualitative study among stakeholders CL Bekker, H Gardarsdottir, TCG Egberts, ML Bouvy, BJF van den Bemt International journal of clinical pharmacy 39, 196-204, 2017 | 47 | 2017 |
| Use of real‐world data and evidence in drug development of medicinal products centrally authorized in Europe in 2018–2019 SM Eskola, HGM Leufkens, A Bate, ML De Bruin, H Gardarsdottir Clinical Pharmacology & Therapeutics 111 (1), 310-320, 2022 | 44 | 2022 |
| Methodological comparison of marginal structural model, time‐varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture MS Ali, RHH Groenwold, SV Belitser, PC Souverein, E Martín, NM Gatto, ... Pharmacoepidemiology and drug safety 25, 114-121, 2016 | 41 | 2016 |
| Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy CL Bekker, EJ Melis, ACG Egberts, ML Bouvy, H Gardarsdottir, ... Research in Social and Administrative Pharmacy 15 (1), 100-105, 2019 | 39 | 2019 |